Data through FY2026 Q3 (Jun 30, 2026)
Ascendia Pharmaceuticals, Inc.
Company profile for Ascendia Pharmaceuticals, Inc. covers 7 filings across the reporting window. FY2026 certified median offer: $121,998.
- FY2026 certified median
- $121,998
- Total filings
- 7
- FY2026 25th–75th percentile
- $107,996–$135,999
- Top job title
- Senior Formulation Scientist
| Fiscal year | Filings | Median | 25th percentile | 75th percentile |
|---|---|---|---|---|
| FY2024 | 3 | $96,949 | $78,475 | $102,475 |
| FY2025 | 2 | $96,431 | $96,056 | $96,807 |
| FY2026 (Q1–Q3) | 2 | $121,998 | $107,996 | $135,999 |
FY2026 is partial (*). Its filing totals are not comparable to a full fiscal year.
Median offer by fiscal year
Top titles
- Senior Formulation Scientist2 filings
- Associate, IT & Data Engineering1 filings
- Lead, Business Development1 filings
- Senior Analytical Scientist AR&D1 filings
- Senior Project Manager1 filings
- Senior Scientist1 filings
Top cities
- North Brunswick6 filings
- New Brunswick1 filings